바소조신정 2mg
Pricing inquiry (see details)
▶ Manufacturer: Ilhwa Co., Ltd.
▶ Sold by: Ilhwa Co., Ltd.
▶ Insurance code : 640900410
▶ Storage : Airtight container, store at room temperature (1~30℃)
This item has been added to your cart.
Should I order it along with the items in my shopping cart?
Check location
Check location
031-550-0100
+ Appearance Light orange circular tablet + Active ingredient(s) Terazosin HCl 2.374mg (2mg as Terazosin) + Administration and dose This drug may be administered in single therapy or in concomitant therapy with thiazide diuretics or other hypotensive agents if other drugs are inappropriate or ineffective. Food has no or almost no effect on the bioavailability of this drug, and therefore the drug may be administered regardless of meals. Increase or reduce according to age and symptoms. 1. Voiding dysfunction due to benign prostatic hyperplasia Adults 1) Initial dose Orally administer initial dose of 1mg terazosin HCl before sleep. Do not exceed this dose. To minimize the possibility of acute hypotension due to first administration, carefully observe medication adherence for initial administration. 2) Maintenance dose Slowly increase dose until symptoms are improved. Orally administer 5 to 10mg once a day as the maintenance dose. 3) Concomitant administration with thiazide diuretics and other hypotensive agents: Reduce dose of this drug when administering concomitantly with thiazide diuretics or other hypotensive agents, and increase if necessary. Carefully observe during such concomitant therapy as hypotension may occur. 2. Hypertension Adjust dose according to patient’s blood pressure response. |
Adults 1) Initial dose Orally administer initial dose of 1mg terazosin HCl before sleep. Do not exceed this dose. To minimize the possibility of acute hypotension due to first administration, carefully observe medication adherence for initial administration. 2) Maintenance dose (1) Single therapy: Administer 2 to 10mg once a day as the maintenance dose in the morning or evening, preferably at the same time every day. To achieve the desired blood pressure response, dose may be doubled at 1 week intervals. Administration of doses exceeding 20mg does not result in greater results, and no studies have been carried out on administration of doses of 40mg or greater. (2) Concomitant administration with thiazide diuretics and other hypotensive agents: Reduce dose of this drug when administering concomitantly with thiazide diuretics or other hypotensive agents, and increase if necessary. Carefully observe during such concomitant therapy as hypotension may occur. + Indications Voiding dysfunction due to benign prostatic hyperplasia, hypertension (mild to moderately severe) |
+ Appearance Light orange circular tablet + Active ingredient(s) Terazosin HCl 2.374mg (2mg as Terazosin) + Administration and dose This drug may be administered in single therapy or in concomitant therapy with thiazide diuretics or other hypotensive agents if other drugs are inappropriate or ineffective. Food has no or almost no effect on the bioavailability of this drug, and therefore the drug may be administered regardless of meals. Increase or reduce according to age and symptoms. 1. Voiding dysfunction due to benign prostatic hyperplasia Adults 1) Initial dose Orally administer initial dose of 1mg terazosin HCl before sleep. Do not exceed this dose. To minimize the possibility of acute hypotension due to first administration, carefully observe medication adherence for initial administration. 2) Maintenance dose Slowly increase dose until symptoms are improved. Orally administer 5 to 10mg once a day as the maintenance dose. 3) Concomitant administration with thiazide diuretics and other hypotensive agents: Reduce dose of this drug when administering concomitantly with thiazide diuretics or other hypotensive agents, and increase if necessary. Carefully observe during such concomitant therapy as hypotension may occur. 2. Hypertension Adjust dose according to patient’s blood pressure response. |
Adults 1) Initial dose Orally administer initial dose of 1mg terazosin HCl before sleep. Do not exceed this dose. To minimize the possibility of acute hypotension due to first administration, carefully observe medication adherence for initial administration. 2) Maintenance dose (1) Single therapy: Administer 2 to 10mg once a day as the maintenance dose in the morning or evening, preferably at the same time every day. To achieve the desired blood pressure response, dose may be doubled at 1 week intervals. Administration of doses exceeding 20mg does not result in greater results, and no studies have been carried out on administration of doses of 40mg or greater. (2) Concomitant administration with thiazide diuretics and other hypotensive agents: Reduce dose of this drug when administering concomitantly with thiazide diuretics or other hypotensive agents, and increase if necessary. Carefully observe during such concomitant therapy as hypotension may occur. + Indications Voiding dysfunction due to benign prostatic hyperplasia, hypertension (mild to moderately severe) |